Physical Wellness · ScienceDaily Chronic Illness · September 1, 2026

Goodbye CPAP? New sleep apnea pill cuts breathing events by 44%

A once-nightly pill cut breathing interruptions by about 44% in a major phase 3 sleep apnea trial, while improving oxygen levels and disease severity. By strengthening the muscles that keep the airway open during sleep, AD109 could offer a new option for people unable to tolerate CPAP.

Originally published by ScienceDaily Chronic Illness. We curate and add context; they did the reporting.

Read the full story at ScienceDaily Chronic Illness ↗

Related learning

Herpes Simplex Virus and Cancer: What Patients Should Know Scientists discover mysterious “lonely” brain waves linked to memory loss A surprising discovery could help aging muscles repair themselves The Pilates Bros Have Arrived